|
|
| |
| Most Discussed Stocks |
 |
|
|
|
|
|
Biotech News and Comments |
|
WE ARE BACK FROM HALF REST, GILEAD, TYSABRI AND OTHER STORIES |
| January is almost gone, and February is knocking on the door. Be ready to hear good news. We have plenty. For subscribers Only. |
|
more |
|
News and Comments |
more |
|
 |
SUNESIS PHARMACEUTICALS (SNSS): RESULTS CANNO.... |
01/02/2010 |
| |
At the 51st American Society Hematology (ASH) Annual Meeting in New Orleans, LA. Sunesis presented positive data from two Phase 2 clinical trials of its drug Voreloxin drug for acu....
|
 |
CompuGen (CGEN): Biotech firms are no dreamer.... |
12/23/2009 |
| |
The high-risk biotech firms are proving time after time that they are low risk. Now, following the melting of the economy story, the biotech firms can be seen as no risk compared t....
|
|
| |
Latest News Posted to subscribers |
more |
|
|
|
| |
|
|
|
Topics |
 |
|
|
| |
|
| |
|
|